Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors is a research paper published in JAMA Network Open (2021). On theSindex it has a DataRank of 0. It has been cited 22 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
NIAAA NIH HHS
Grant: K01 AA028258
NHLBI NIH HHS
Grant: T35 HL007649
NCATS NIH HHS
Grant: UL1 TR001863
National Institutes of Health
Grant: 1U01FD004585-01
Optimizing Medical Device Post-Market Surveillance for Public Value
National Institutes of Health
Grant: 1R01HS022882-01
Understanding hospital readmission rates: patient, hospital and community effects
National Institutes of Health
Grant: 5U01FD005938-04
Yale-Mayo Clinic FDA Center of Excellence in Regulatory Science and Innovation (CERSI)
National Institutes of Health
Grant: 5K01AA028258-04
Identifying patient subgroups that are most likely to benefit from medications used to treat alcohol use disorder
National Institutes of Health
Grant: 2T35HL007649-31
Short Term Research Training: Students in Health Professional Schools
FWCI
2.02
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals